The Biological Computing Company (TBC) has raised $25 million in a Series C round led by Primary Venture Partners, with participation from Builders VC, Refactor Capital, Wonder Ventures, E1 Ventures, Proximity and Tusk Ventures. The company has become the first ever paid by a customer for biological compute — a commercial transaction for computational work performed by living neurons. TBC connects living neurons to electrodes and uses them as a computing substrate alongside AI systems. Its first product has demonstrated a 23-times improvement in video model efficiency. The company leverages biology's energy advantage: the human brain delivers approximately one exaflop of power on 20 watts, whilst NVIDIA's Blackwell requires around 120,000 watts for equivalent throughput. Founded in 2021 by neurosurgeons Alex Ksendzovsky and Jon Pomeraniec, TBC represents the commercialisation of a new computing substrate addressing AI infrastructure's escalating energy demands.

Living neurons integrated into modern AI processing, claims SF startup - biological computing power used to boost computer vision, generative video, and more. By Mark Tyson published 3 hours ago The Biological Computing Company (TBC) has just raised $25m, despite its admitted decades-long plans for real-time compute implementation. A San Francisco-based startup claims to be the first to have created a biological computing platform built from living neurons, purposed to accelerate artificial intelligence-based tasks. The Biological Computing Company (TBC) reckons this is a credible pathway to replace, or augment, silicon compute in AI, with support for processes like "computer vision, generative video, and AI infrastructure." Alongside the bold claims, it is revealed that TBC has secured $25m in funding from its initial seed round and will open a new flagship lab in the city. TBC was founded by two neuroscientists who are seeking to use "the most elusive, yet obvious idea in computer science - using the real brain for computing," notes an email received by Tom's Hardware. Moreover, the communication boasts that "biological computing can process foundational AI models 5x faster than silicon-based chips alone, requiring less power, generating greater accuracy, and reaching the scale that today's AI ecosystem requires." It is this kind of bold vision for a new class of AI infrastructure that has inspired the delivery of $25m in funding. However, at this early stage, we note that little of real substance has been publicly revealed to satisfy the curious minds of Tom's Hardware readers. We did enjoy looking at some of the computer vision, generative video, and algorithm discovery results found in the 'Today' section of TBC's home page, though. Latest Videos From Tom's Hardware The details we have about TBC's work say that the firm "encodes real-world data (e.g., images, video) into living neurons, then decodes neural activity into richer representations mapped onto state-of-the-art AI models through modular adapters." This is piped through TBC's Algorithm Discovery platform to bolster the AI compute layer. Thus, in effect, the TBC wetware and software works on the intersection of neuroscience and AI. That seems fitting, as TBC co-founders Alex Ksendsovsky, MD, PhD, and Jon Pomeraniec, MD, MBA, are both neurosurgeon-neuroscientists. "We're at the ground level of paradigm shift, of what comes next, after language, after silicon," says Pomeraniec. The promise of "building infrastructure to understand and interact with the world in a fundamentally new way" is tantalizing, but the details publicly shared by the company so far are too vague to properly assess. This concern is magnified by the very bold claims of TBC. Moreover, we've seen some interviews with the co-founders talk about a ten-to-20-year plan for its neurons in real-time compute integration. So, please stay tuned for a decade or two. Follow Tom's Hardware on Google News, or add us as a preferred source, to get our latest news, analysis, & reviews in your feeds. Get Tom's Hardware's best news and in-depth reviews, straight to your inbox.

The Biological Computing Co. (TBC) has raised $25 million in seed funding, Fortune has learned.